Suppr超能文献

减重手术与肾脏疾病:对安全性和术后肾脏结局的 5 年评估。

Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes.

机构信息

Department of Surgery, Mayo Clinic, Rochester, MN, USA.

Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

Surg Endosc. 2024 Jul;38(7):4014-4023. doi: 10.1007/s00464-024-10983-9. Epub 2024 Jun 13.

Abstract

BACKGROUND

Obesity and its related medical conditions are well-established contributors to the development of chronic kidney disease (CKD). Metabolic and bariatric surgery (MBS), including procedures such as sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), is a potential intervention for these individuals. However, the heightened risk of postoperative complications casts doubts on the suitability of MBS in this population. Our aim is to evaluate the long-term safety, anthropometric and renal outcomes of MBS in patients with CKD.

METHODS

A retrospective review of patients who underwent primary laparoscopic MBS with a BMI ≥ 35 kg/m and a preoperative diagnosis of stage 2 to 5 CKD. Criteria for CKD diagnosis and staging were based on estimated glomerular filtration rate measurements in accordance with established guidelines. Anthropometric and renal outcomes were measured at 3-, 6-, 12-, 24- and 60-months postoperatively.

RESULTS

A total of 302 patients (177 SG, 125 RYGB) were included. RYGB was preferred for patients with stage 3 CKD, while SG was more common in stages 4 and 5. At 5-year follow-up, percentage of total weight loss was higher in the RYGB cohort compared to SG (25.1% vs. 18.6%, p = 0.036). Despite SG patients having more advanced CKD, the incidence of late complications was significantly higher following RYGB, with 11 incidents (8.8%), compared to the SG cohort with only 4 cases (2.3%) (p = 0.014). In those with preoperative CKD stage 3, 76 patients (43.2%) improved to stage 2, with another 9 patients (5.1%) improving further to stage 1. Of all patients, 63 (20.8%) eventually received a successful renal transplant.

CONCLUSIONS

MBS is an effective strategy for sustained weight loss in patients with CKD with acceptable complications rates. RYGB leads to a higher percentage of overall weight loss, albeit with an elevated likelihood of late surgical complications. Future studies are needed to determine the safety of MBS in this demographic.

摘要

背景

肥胖及其相关的医疗条件是慢性肾脏病(CKD)发展的重要因素。代谢和减重手术(MBS),包括袖状胃切除术(SG)和 Roux-en-Y 胃旁路术(RYGB)等手术,是这些患者的潜在干预手段。然而,手术后并发症风险增加,使得 MBS 在这一人群中的适用性受到质疑。我们的目的是评估 MBS 在 CKD 患者中的长期安全性、人体测量学和肾脏结局。

方法

回顾性分析了 302 例 BMI≥35kg/m2且术前诊断为 2 至 5 期 CKD 的患者,这些患者接受了初次腹腔镜 MBS。CKD 的诊断和分期标准是根据既定指南基于估算肾小球滤过率测量值确定的。术后 3、6、12、24 和 60 个月时测量人体测量学和肾脏结局。

结果

共纳入 302 例患者(177 例行 SG,125 例行 RYGB)。对于 3 期 CKD 患者,更倾向于行 RYGB,而对于 4 期和 5 期 CKD 患者,则更常见 SG。在 5 年随访时,RYGB 组的总体重减轻百分比高于 SG 组(25.1% vs. 18.6%,p=0.036)。尽管 SG 患者的 CKD 更严重,但 RYGB 后晚期并发症的发生率明显更高,有 11 例(8.8%),而 SG 组仅有 4 例(2.3%)(p=0.014)。在术前 CKD 3 期的 76 例患者中,有 76 例(43.2%)改善至 2 期,另有 9 例(5.1%)进一步改善至 1 期。所有患者中,有 63 例(20.8%)最终成功接受了肾移植。

结论

MBS 是 CKD 患者持续减重的有效策略,并发症发生率可接受。RYGB 导致总体体重减轻的百分比更高,但晚期手术并发症的可能性增加。需要进一步研究来确定该人群中 MBS 的安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验